Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM: Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)

Tatiana Oviedo-Salcedo, Lot de Witte, Tania Kümpfel, René S Kahn, Peter Falkai, Peter Eichhorn, Jurjen Luykx, Alkomiet Hasan

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

In the reference list, number 11 is stated incorrectly. The correct reference for 11 is: Dyalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology 2011; 10(1):63-74. The authors regret the error.

Original languageEnglish
Pages (from-to)561
Number of pages1
JournalBritish Journal of Psychiatry
Volume213
Issue number3
Early online date10 Jul 2018
DOIs
Publication statusPublished - Sept 2018

Keywords

  • Journal Article

Fingerprint

Dive into the research topics of 'Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM: Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders (The British Journal of Psychiatry (2018) (1-3) DOI: 10.1192/bjp.2018.24)'. Together they form a unique fingerprint.

Cite this